Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.76 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | CA12 | O43570 | 1/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
| ▸ | CA4 | P22748 | 1/20 | 0.69 |
| ▸ | CA6 | P23280 | 1/20 | 0.69 |
| ▸ | CA7 | P43166 | 1/20 | 0.69 |
| ▸ | TPMT | P51580 | 1/20 | 0.69 |
| ▸ | CA9 | Q16790 | 1/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.69 |
| ▸ | HTT | P42858 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 2/20 | 0.62 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.62 |
| ▸ | PKM | P14618 | 3/20 | 0.60 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31652866 | 1.00 | ALDH1A1 (0.76) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| Benzoic Acid SCHEMBL11509726 | 0.93 | CYP1A2 (0.77) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| SCHEMBL27630437 | 0.86 | ALDH1A1 (1.00) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| SCHEMBL7502240 | 0.86 | ALDH1A1 (0.62) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| SCHEMBL313116 | 0.85 | ALDH1A1 (0.76) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| SCHEMBL644265 | 0.85 | CA12 (0.69) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| SCHEMBL29810107 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| SCHEMBL36283 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| SCHEMBL8156286 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 | |
| SCHEMBL1287590 | 0.83 | ALDH1A1 (0.73) | ALDH1A1CYP1A2CYP2D6HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 318 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | claimed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | claimed |
| CN-118973990-A | Process for producing cyclic diketone compound | 花王株式会社 | 2024-11-15 | — | — | CN | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| WO-2023189722-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | 花王株式会社 | 2023-10-05 | — | — | WO | claimed |
| CN-103102263-A | 3-bromine-4-methoxybenzoic acid preparation method and agricultural biological activity | UNIV QINGDAO AGRICULTURAL | 2013-05-15 | — | — | CN | claimed |
| EP-4743457-A1 | INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR THERAPEUTIC USE | 4M THERAPEUTICS INC. (US) | 2026-05-20 | — | — | EP | disclosed |
| CN-122059950-A | Compounds with proteasome agonistic activity, preparation method and application thereof | 浙大城市学院 | 2026-05-19 | — | — | CN | disclosed |
| EP-4652154-A1 | NOVEL ALPK1 INHIBITORS | Pyrotech (Beijing) Biotechnology Co., Ltd. (CN) | 2025-11-26 | — | — | EP | disclosed |
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| CN-120192323-A | Pyrrolidone-containing compounds | 正大天晴药业集团股份有限公司 | 2025-06-24 | — | — | CN | disclosed |
| EP-4501897-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| EP-0124476-B1 | CARBOXAMIDES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | CIBA-GEIGY AG (CH) | 1988-06-22 | — | — | EP | disclosed |
| EP-0244088-A2 | 1-Phenyl-3-benzazepine compounds and medicaments containing these compounds for treating gastrointestinal motility disorders | SMITHKLINE BEECHAM CORPORATION (US) | 1987-11-04 | — | — | EP | disclosed |
| US-4559349-A | TREATMENT OF PHYCHOSIS | CIBA GEIGY CORPORATION (US) | 1985-12-17 | — | — | US | disclosed |
| US-4508911-A | Amine intermediates for analgesic compounds | THE UPJOHN COMPANY (US) | 1985-04-02 | — | — | US | disclosed |
| EP-0124476-A1 | Carboxamides, process for their preparation and pharmaceutical preparations containing them | CIBA-GEIGY AG (CH) | 1984-11-07 | — | — | EP | disclosed |
| US-4438130-A | Analgesic 1-oxa-, aza- and thia-spirocyclic compounds | THE UPJOHN COMPANY (US) | 1984-03-20 | — | — | US | disclosed |
| US-4346101-A | NON-SEDATING | THE UPJOHN COMPANY (US) | 1982-08-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | CYP4F2, DUOX1, BCKDK | ALDH1A1 973/4885CYP1A2 114/4885CYP2D6 189/4885 |
| US-20250214921-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | HSD17B7, HSD17B12, BCKDK | ALDH1A1 699/4885CYP1A2 201/4885CYP2D6 244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.